Utility of Erythrocyte Sedimentation Rate and C-Reactive Protein for the Diagnosis of Giant Cell Arteritis
To evaluate the utility of erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) for the diagnosis of giant cell arteritis (GCA) and to determine the frequency of normal ESR and CRP at diagnosis of GCA. All patients undergoing temporal artery biopsy (TAB) between 2000 and 2008 were ident...
Saved in:
Published in | Seminars in arthritis and rheumatism Vol. 41; no. 6; pp. 866 - 871 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.06.2012
|
Subjects | |
Online Access | Get full text |
ISSN | 0049-0172 1532-866X 1532-866X |
DOI | 10.1016/j.semarthrit.2011.10.005 |
Cover
Loading…
Abstract | To evaluate the utility of erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) for the diagnosis of giant cell arteritis (GCA) and to determine the frequency of normal ESR and CRP at diagnosis of GCA.
All patients undergoing temporal artery biopsy (TAB) between 2000 and 2008 were identified. Only subjects with both ESR and CRP at the time of TAB were included. The medical records of all patients were reviewed.
We included 764 patients (65% women), mean age 72.7 (±9.27) years, who underwent TAB. Biopsy was consistent with GCA in 177 patients (23%). Elevated CRP and elevated ESR provided a sensitivity of 86.9% and 84.1%, respectively, for a positive TAB. The odds ratio of a concordantly elevated ESR and CRP for positive TAB was 3.06 (95% CI 2.03, 4.62), whereas the odds ratio for concordantly normal ESR and CRP was 0.49 (95% CI 0.29, 0.83). Seven patients (4%) with a positive TAB for GCA had a normal ESR and CRP at diagnosis. Compared with GCA patients with elevated markers of inflammation, a greater proportion of these patients had polymyalgia rheumatica symptoms (P = 0.008), whereas constitutional symptoms, anemia and thrombocytosis, were observed less often (P < 0.05).
CRP is a more sensitive marker than ESR for a positive TAB that is diagnostic of GCA. There may be clinical utility in obtaining both tests in the evaluation of patients with suspected GCA. A small proportion of patients with GCA may have normal inflammatory markers at diagnosis. |
---|---|
AbstractList | To evaluate the utility of erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) for the diagnosis of giant cell arteritis (GCA) and to determine the frequency of normal ESR and CRP at diagnosis of GCA.
All patients undergoing temporal artery biopsy (TAB) between 2000 and 2008 were identified. Only subjects with both ESR and CRP at the time of TAB were included. The medical records of all patients were reviewed.
We included 764 patients (65% women), mean age 72.7 (±9.27) years, who underwent TAB. Biopsy was consistent with GCA in 177 patients (23%). Elevated CRP and elevated ESR provided a sensitivity of 86.9% and 84.1%, respectively, for a positive TAB. The odds ratio of a concordantly elevated ESR and CRP for positive TAB was 3.06 (95% CI 2.03, 4.62), whereas the odds ratio for concordantly normal ESR and CRP was 0.49 (95% CI 0.29, 0.83). Seven patients (4%) with a positive TAB for GCA had a normal ESR and CRP at diagnosis. Compared with GCA patients with elevated markers of inflammation, a greater proportion of these patients had polymyalgia rheumatica symptoms (P = 0.008), whereas constitutional symptoms, anemia and thrombocytosis, were observed less often (P < 0.05).
CRP is a more sensitive marker than ESR for a positive TAB that is diagnostic of GCA. There may be clinical utility in obtaining both tests in the evaluation of patients with suspected GCA. A small proportion of patients with GCA may have normal inflammatory markers at diagnosis. To evaluate the utility of erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) for the diagnosis of giant cell arteritis (GCA) and to determine the frequency of normal ESR and CRP at diagnosis of GCA.OBJECTIVESTo evaluate the utility of erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) for the diagnosis of giant cell arteritis (GCA) and to determine the frequency of normal ESR and CRP at diagnosis of GCA.All patients undergoing temporal artery biopsy (TAB) between 2000 and 2008 were identified. Only subjects with both ESR and CRP at the time of TAB were included. The medical records of all patients were reviewed.METHODSAll patients undergoing temporal artery biopsy (TAB) between 2000 and 2008 were identified. Only subjects with both ESR and CRP at the time of TAB were included. The medical records of all patients were reviewed.We included 764 patients (65% women), mean age 72.7 (±9.27) years, who underwent TAB. Biopsy was consistent with GCA in 177 patients (23%). Elevated CRP and elevated ESR provided a sensitivity of 86.9% and 84.1%, respectively, for a positive TAB. The odds ratio of a concordantly elevated ESR and CRP for positive TAB was 3.06 (95% CI 2.03, 4.62), whereas the odds ratio for concordantly normal ESR and CRP was 0.49 (95% CI 0.29, 0.83). Seven patients (4%) with a positive TAB for GCA had a normal ESR and CRP at diagnosis. Compared with GCA patients with elevated markers of inflammation, a greater proportion of these patients had polymyalgia rheumatica symptoms (P = 0.008), whereas constitutional symptoms, anemia and thrombocytosis, were observed less often (P < 0.05).RESULTSWe included 764 patients (65% women), mean age 72.7 (±9.27) years, who underwent TAB. Biopsy was consistent with GCA in 177 patients (23%). Elevated CRP and elevated ESR provided a sensitivity of 86.9% and 84.1%, respectively, for a positive TAB. The odds ratio of a concordantly elevated ESR and CRP for positive TAB was 3.06 (95% CI 2.03, 4.62), whereas the odds ratio for concordantly normal ESR and CRP was 0.49 (95% CI 0.29, 0.83). Seven patients (4%) with a positive TAB for GCA had a normal ESR and CRP at diagnosis. Compared with GCA patients with elevated markers of inflammation, a greater proportion of these patients had polymyalgia rheumatica symptoms (P = 0.008), whereas constitutional symptoms, anemia and thrombocytosis, were observed less often (P < 0.05).CRP is a more sensitive marker than ESR for a positive TAB that is diagnostic of GCA. There may be clinical utility in obtaining both tests in the evaluation of patients with suspected GCA. A small proportion of patients with GCA may have normal inflammatory markers at diagnosis.CONCLUSIONSCRP is a more sensitive marker than ESR for a positive TAB that is diagnostic of GCA. There may be clinical utility in obtaining both tests in the evaluation of patients with suspected GCA. A small proportion of patients with GCA may have normal inflammatory markers at diagnosis. Objectives To evaluate the utility of erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) for the diagnosis of giant cell arteritis (GCA) and to determine the frequency of normal ESR and CRP at diagnosis of GCA. Methods All patients undergoing temporal artery biopsy (TAB) between 2000 and 2008 were identified. Only subjects with both ESR and CRP at the time of TAB were included. The medical records of all patients were reviewed. Results We included 764 patients (65% women), mean age 72.7 (±9.27) years, who underwent TAB. Biopsy was consistent with GCA in 177 patients (23%). Elevated CRP and elevated ESR provided a sensitivity of 86.9% and 84.1%, respectively, for a positive TAB. The odds ratio of a concordantly elevated ESR and CRP for positive TAB was 3.06 (95% CI 2.03, 4.62), whereas the odds ratio for concordantly normal ESR and CRP was 0.49 (95% CI 0.29, 0.83). Seven patients (4%) with a positive TAB for GCA had a normal ESR and CRP at diagnosis. Compared with GCA patients with elevated markers of inflammation, a greater proportion of these patients had polymyalgia rheumatica symptoms ( P = 0.008), whereas constitutional symptoms, anemia and thrombocytosis, were observed less often ( P < 0.05). Conclusions CRP is a more sensitive marker than ESR for a positive TAB that is diagnostic of GCA. There may be clinical utility in obtaining both tests in the evaluation of patients with suspected GCA. A small proportion of patients with GCA may have normal inflammatory markers at diagnosis. |
Author | Schmidt, Jean Hunder, Gene G. Kermani, Tanaz A. Matteson, Eric L. Warrington, Kenneth J. Ytterberg, Steven R. Crowson, Cynthia S. |
AuthorAffiliation | 2 Department of Internal Medicine, Amiens University Hospital, Amiens, France 3 Division of Biostatistics, Department of Health Sciences Research of, Mayo Clinic, Rochester, USA 1 Division of Rheumatology, Department of Medicine, Mayo Clinic, Rochester, USA |
AuthorAffiliation_xml | – name: 3 Division of Biostatistics, Department of Health Sciences Research of, Mayo Clinic, Rochester, USA – name: 1 Division of Rheumatology, Department of Medicine, Mayo Clinic, Rochester, USA – name: 2 Department of Internal Medicine, Amiens University Hospital, Amiens, France |
Author_xml | – sequence: 1 givenname: Tanaz A. surname: Kermani fullname: Kermani, Tanaz A. email: kermani.tanaz@mayo.edu organization: Division of Rheumatology, Department of Medicine, Mayo Clinic, Rochester, MN – sequence: 2 givenname: Jean surname: Schmidt fullname: Schmidt, Jean organization: Department of Internal Medicine, Amiens University Hospital, Amiens, France – sequence: 3 givenname: Cynthia S. surname: Crowson fullname: Crowson, Cynthia S. organization: Division of Rheumatology, Department of Medicine, Mayo Clinic, Rochester, MN – sequence: 4 givenname: Steven R. surname: Ytterberg fullname: Ytterberg, Steven R. organization: Division of Rheumatology, Department of Medicine, Mayo Clinic, Rochester, MN – sequence: 5 givenname: Gene G. surname: Hunder fullname: Hunder, Gene G. organization: Division of Rheumatology, Department of Medicine, Mayo Clinic, Rochester, MN – sequence: 6 givenname: Eric L. surname: Matteson fullname: Matteson, Eric L. organization: Division of Rheumatology, Department of Medicine, Mayo Clinic, Rochester, MN – sequence: 7 givenname: Kenneth J. surname: Warrington fullname: Warrington, Kenneth J. organization: Division of Rheumatology, Department of Medicine, Mayo Clinic, Rochester, MN |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/22119103$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkU9v1DAQxS1URLeFr4B85JLFdjZxckGUpbRIlUAtlbhZjj3pTsjare1dKd8eR_0HByROlsZPv3nz3hE5cN4BIZSzJWe8fj8sI2x1SJuAaSkY53m8ZKx6QRa8KkXR1PXPA7JgbNUWjEtxSI5iHFgW1ky-IodCcN5yVi7IcJ1wxDRR39PTMGWiN1MCegUWt-CSTugdvdR5pJ2l6-IStEm4B_o9-AToaO8DTRugn1HfOB8xzqgz1C7RNYwjPQkJsk2Mr8nLXo8R3jy8x-T6y-mP9Xlx8e3s6_rkooBVKVPRVlXfdFZy27a2k1obWIkSODArbCd0Y7u6trrnDEwj64aZqhHQSd5xw6qqLI_Jh3vu7a7bgjX5iqBHdRswRzYpr1H9_eNwo278XpUlk03LM-DdAyD4ux3EpLYYTb5FO_C7qHIFlazqlq2y9O2fu56WPAacBZ_uBZAv3iMEFQ2CMzneACYp6zHzZmStBvXcqppbnX9yq88XPUHMiA6NHn_BBHHwu-ByooqrKBRTV3Pvc-2cs2xBzjY__hvwfx5-A15Jxvk |
ContentType | Journal Article |
Copyright | 2012 Elsevier Inc. Elsevier Inc. Copyright © 2012 Elsevier Inc. All rights reserved. 2011 Elsevier Inc. All rights reserved. 2011 |
Copyright_xml | – notice: 2012 Elsevier Inc. – notice: Elsevier Inc. – notice: Copyright © 2012 Elsevier Inc. All rights reserved. – notice: 2011 Elsevier Inc. All rights reserved. 2011 |
DBID | CGR CUY CVF ECM EIF NPM 7X8 5PM |
DOI | 10.1016/j.semarthrit.2011.10.005 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1532-866X |
EndPage | 871 |
ExternalDocumentID | PMC3307891 22119103 S0049017211003374 1_s2_0_S0049017211003374 |
Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NIAMS NIH HHS grantid: U54 AR057319 – fundername: NCRR NIH HHS grantid: U54 RR019497 – fundername: NCRR NIH HHS grantid: U54RR019497 – fundername: NIAMS NIH HHS grantid: U54AR057319 – fundername: National Institute of Arthritis and Musculoskeletal and Skin Diseases : NIAMS grantid: U54 AR057319-09 || AR |
GroupedDBID | --- --K --M .1- .FO .GJ .~1 0R~ 123 1B1 1P~ 1RT 1~. 1~5 3O- 4.4 457 4G. 53G 5RE 5VS 7-5 71M 8P~ 9JM AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQQT AAQXK AATTM AAWTL AAXKI AAXUO AAYWO ABBQC ABFRF ABJNI ABLJU ABMAC ABMZM ABWVN ABXDB ACDAQ ACGFO ACIEU ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEVXI AFFNX AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGHFR AGQPQ AGUBO AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV BR6 CAG COF CS3 DU5 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HDU HMK HMO HVGLF HZ~ IHE J1W J5H K-O KOM L7B M29 M41 MO0 N9A O-L O9- OAUVE OI0 OV- OZT P-8 P-9 P2P PC. Q38 QTD R2- ROL RPZ SAE SDF SDG SDP SEL SES SEW SPCBC SSH SSZ T5K UNMZH WUQ XFW Z5R ZGI ~G- AACTN AFCTW AFKWA AJOXV AMFUW RIG AAIAV ABLVK ABYKQ AJBFU EFLBG LCYCR AGRNS CGR CUY CVF ECM EIF NPM 7X8 5PM |
ID | FETCH-LOGICAL-e437t-955f8bd71d99db7aace423e1e0d2db2a8db66daf10ec87680c582eb71b1c05533 |
IEDL.DBID | .~1 |
ISSN | 0049-0172 1532-866X |
IngestDate | Thu Aug 21 13:53:14 EDT 2025 Thu Jul 10 18:12:51 EDT 2025 Mon Jul 21 06:07:30 EDT 2025 Fri Feb 23 02:27:52 EST 2024 Sun Feb 23 10:19:05 EST 2025 Tue Aug 26 17:21:20 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | erythrocyte sedimentation rate giant cell arteritis C-reactive protein temporal artery biopsy polymyalgia rheumatica |
Language | English |
License | Copyright © 2012 Elsevier Inc. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-e437t-955f8bd71d99db7aace423e1e0d2db2a8db66daf10ec87680c582eb71b1c05533 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 22119103 |
PQID | 1015756904 |
PQPubID | 23479 |
PageCount | 6 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3307891 proquest_miscellaneous_1015756904 pubmed_primary_22119103 elsevier_sciencedirect_doi_10_1016_j_semarthrit_2011_10_005 elsevier_clinicalkeyesjournals_1_s2_0_S0049017211003374 elsevier_clinicalkey_doi_10_1016_j_semarthrit_2011_10_005 |
PublicationCentury | 2000 |
PublicationDate | 2012-06-01 |
PublicationDateYYYYMMDD | 2012-06-01 |
PublicationDate_xml | – month: 06 year: 2012 text: 2012-06-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Seminars in arthritis and rheumatism |
PublicationTitleAlternate | Semin Arthritis Rheum |
PublicationYear | 2012 |
Publisher | Elsevier Inc |
Publisher_xml | – name: Elsevier Inc |
References | Kermani, Schafer, Crowson, Hunder, Gabriel, Matteson (bib2) 2010; 69 Walvick, Walvick (bib5) 2011; 118 Hayreh, Podhajsky, Raman, Zimmerman (bib6) 1997; 123 Smetana, Shmerling (bib9) 2002; 287 Ellis, Ralston (bib10) 1983; 42 Parikh, Miller, Lee, Savino, Vacarezza, Cornblath (bib8) 2006; 113 Salvarani, Cantini, Hunder (bib1) 2008; 372 Martinez-Taboada, Blanco, Armona, Uriarte, Figueroa, Gonzalez-Gay (bib14) 2000; 19 Kyle, Cawston, Hazleman (bib11) 1989; 48 Cid, Font, Oristrell, de la Sierra, Coll-Vinent, Lopez-Soto (bib15) 1998; 41 Hunder, Bloch, Michel, Stevens, Arend, Calabrese (bib4) 1990; 33 Myklebust, Gran (bib13) 1996; 35 Salvarani, Hunder (bib7) 2001; 45 Crowson, Matteson, Myasoedova, Michet, Ernste, Warrington (bib3) 2011; 63 Pountain, Calvin, Hazleman (bib12) 1994; 33 |
References_xml | – volume: 123 start-page: 285 year: 1997 end-page: 296 ident: bib6 article-title: Giant cell arteritis: validity and reliability of various diagnostic criteria publication-title: Am J Ophthalmol – volume: 33 start-page: 550 year: 1994 end-page: 554 ident: bib12 article-title: Alpha 1-antichymotrypsin, C-reactive protein and erythrocyte sedimentation rate in polymyalgia rheumatica and giant cell arteritis publication-title: Br J Rheumatol – volume: 33 start-page: 1122 year: 1990 end-page: 1128 ident: bib4 article-title: The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis publication-title: Arthritis Rheum – volume: 118 start-page: 1201 year: 2011 end-page: 1204 ident: bib5 article-title: Giant cell arteritis: laboratory predictors of a positive temporal artery biopsy publication-title: Ophthalmology – volume: 113 start-page: 1842 year: 2006 end-page: 1845 ident: bib8 article-title: Prevalence of a normal C-reactive protein with an elevated erythrocyte sedimentation rate in biopsy-proven giant cell arteritis publication-title: Ophthalmology – volume: 41 start-page: 26 year: 1998 end-page: 32 ident: bib15 article-title: Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis publication-title: Arthritis Rheum – volume: 69 start-page: 780 year: 2010 end-page: 781 ident: bib2 article-title: Increase in age at onset of giant cell arteritis: a population-based study publication-title: Ann Rheum Dis – volume: 35 start-page: 1161 year: 1996 end-page: 1168 ident: bib13 article-title: A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis publication-title: Br J Rheumatol – volume: 287 start-page: 92 year: 2002 end-page: 101 ident: bib9 article-title: Does this patient have temporal arteritis? publication-title: JAMA – volume: 372 start-page: 234 year: 2008 end-page: 245 ident: bib1 article-title: Polymyalgia rheumatica and giant-cell arteritis publication-title: Lancet – volume: 48 start-page: 667 year: 1989 end-page: 671 ident: bib11 article-title: Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow up publication-title: Ann Rheum Dis – volume: 63 start-page: 633 year: 2011 end-page: 639 ident: bib3 article-title: The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases publication-title: Arthritis Rheum – volume: 42 start-page: 168 year: 1983 end-page: 170 ident: bib10 article-title: The ESR in the diagnosis and management of the polymyalgia rheumatica/giant cell arteritis syndrome publication-title: Ann Rheum Dis – volume: 19 start-page: 73 year: 2000 end-page: 75 ident: bib14 article-title: Giant cell arteritis with an erythrocyte sedimentation rate lower than 50 publication-title: Clin Rheumatol – volume: 45 start-page: 140 year: 2001 end-page: 145 ident: bib7 article-title: Giant cell arteritis with low erythrocyte sedimentation rate: frequency of occurrence in a population-based study publication-title: Arthritis Rheum |
SSID | ssj0011607 |
Score | 2.4638333 |
Snippet | To evaluate the utility of erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) for the diagnosis of giant cell arteritis (GCA) and to determine... Objectives To evaluate the utility of erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) for the diagnosis of giant cell arteritis (GCA) and to... |
SourceID | pubmedcentral proquest pubmed elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 866 |
SubjectTerms | Aged Aged, 80 and over Blood Sedimentation C-reactive protein C-Reactive Protein - metabolism Diagnosis, Differential erythrocyte sedimentation rate Female giant cell arteritis Giant Cell Arteritis - blood Giant Cell Arteritis - diagnosis Giant Cell Arteritis - pathology Humans Male Middle Aged polymyalgia rheumatica Polymyalgia Rheumatica - blood Polymyalgia Rheumatica - diagnosis Polymyalgia Rheumatica - pathology Rheumatology Sensitivity and Specificity Temporal Arteries - pathology temporal artery biopsy |
Title | Utility of Erythrocyte Sedimentation Rate and C-Reactive Protein for the Diagnosis of Giant Cell Arteritis |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0049017211003374 https://www.clinicalkey.es/playcontent/1-s2.0-S0049017211003374 https://dx.doi.org/10.1016/j.semarthrit.2011.10.005 https://www.ncbi.nlm.nih.gov/pubmed/22119103 https://www.proquest.com/docview/1015756904 https://pubmed.ncbi.nlm.nih.gov/PMC3307891 |
Volume | 41 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1NT9wwELUQSFUvVb-7pSBX6jXFju0kVk9ogW5bgSralbhZduyIIMgiEg574bd3Jk6WbumhUo-JP2WPx8_ym2dCPlS-kjwPOslklSZScZFYlLtTKITCs9JpjbHDxyfZbC6_nqmzDTIdY2GQVjn4_ujTe289_NkbRnPvuq4xxlfq4QTDhMhRExTV68CmP96taB4cBdTiLTPygvKRzRM5Xm24girP4RgexTx7npda25ce4s4_6ZO_7UdHT8mTAUjS_djXZ2QjNM_Jo-PhqvwFuZh3SHtd0kVFD2-W-BxCuewC_QE5roaAo4aeAtSktvF0mpwG2_s--h2lG-qGApylAA_pQWTj1S1W9RnMqaPTcNk3HXpJpJdkfnT4czpLhocVkiBF3iVaqapwPudea-9ya8sAqCrwwHzqXWoL77LM24qzUIK3LFipijS4nDteMgUA8RXZbBZNeENo4fIK6pKsrIRkriwKy4OsYKSFV0KqCdHjWJox1hO8kwGHbUaC2YW5nweD84ApMA8Tkv-tbGiHZdYabtrUMPPAFCbk06rkmjX9Y7vvx0k3sNjwBsU2YXHbYjGAt5lm0MLraATmOqqCmLTXymMCer1mHqsMKOS9ntLU572gtxAo-s_f_levt8lj-Eojje0d2exubsMOAKbO7fYrYpds7X_5Njv5BTmdGRM |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9wgEEbpRmpzqfpMN31RqVcrYMDY6inaJt002VWVZqXcEBisOGq8Uewc9t93MHjbbXqo1KsxD8EwfGi--UDoY2UrTqUrkoxXacIFZYn2cnfCC6HQrDRF4XOHZ_NsuuBfL8TFFpoMuTCeVhl9f_DpvbeOX_bjbO7f1LXP8eVFvMEQxiR_gLa9OhUfoe2D45PpfB1M8BpqIdDsqUFyIPQEmlfrrqHVS7iJBz3PnuolNo6m-9DzTwblb0fS0RP0OGJJfBCG-xRtueYZejiL0fLn6GrReebrCi8rfHi78i8ilKvO4e_wx3XMOWrwGaBNrBuLJ8mZ0737w9-8ekPdYEC0GBAi_hwIeXXrm_oCFtXhifvRd-16VaQXaHF0eD6ZJvFthcRxJrukEKLKjZXUFoU1UuvSAbBy1BGbWpPq3Joss7qixJXgMHNSijx1RlJDSyIAI75Eo2bZuFcI50ZW0BYnZcU4MWWea-p4BTPNrGBcjFExzKUa0j3BQSnw2WrgmF2pX-ug_Dr4EliHMZJ_q-vauNNaRVWbKqLuWcMYfVrX3DCof-z3w7DoCvabD6Loxi3vWl8NEG5WEOhhNxiBugnCICrt5fIIg1FvmMf6B6_lvVnS1Je9pjdjXvef7v3XqN-jR9Pz2ak6PZ6fvEY7UJIGVtsbNOpu79xbwE-deRf3x0-_yBvE |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Utility+of+erythrocyte+sedimentation+rate+and+C-reactive+protein+for+the+diagnosis+of+giant+cell+arteritis&rft.jtitle=Seminars+in+arthritis+and+rheumatism&rft.au=Kermani%2C+Tanaz+A&rft.au=Schmidt%2C+Jean&rft.au=Crowson%2C+Cynthia+S&rft.au=Ytterberg%2C+Steven+R&rft.date=2012-06-01&rft.eissn=1532-866X&rft.volume=41&rft.issue=6&rft.spage=866&rft_id=info:doi/10.1016%2Fj.semarthrit.2011.10.005&rft_id=info%3Apmid%2F22119103&rft.externalDocID=22119103 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00490172%2FS0049017211X00094%2Fcov150h.gif |